Sodium propionate oral supplementation ameliorates depressive-like behavior through gut microbiome and histone 3 epigenetic regulation

•CUMS is capable of inducing changes in microbiome profiling and brain epigenetics.•Specific gut microbial changes can be associated with a resilience profile to stress.•SCFAs, mainly propionate, are pointed to have a major role in depressive disorder.•Propionate mitigates brain region-specific dysr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nutritional biochemistry 2024-08, Vol.130, p.109660, Article 109660
Hauptverfasser: Behrens, Luiza Marques Prates, Gasparotto, Juciano, Rampelotto, Pabulo Henrique, Escalona, Manuel Adrian Riveros, da Silva, Lucas dos Santos, Carazza-Kessler, Flávio Gabriel, Barbosa, Camila Pocharski, Campos, Marlene Soares, Dorn, Márcio, Gelain, Daniel Pens, Moreira, José Cláudio Fonseca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•CUMS is capable of inducing changes in microbiome profiling and brain epigenetics.•Specific gut microbial changes can be associated with a resilience profile to stress.•SCFAs, mainly propionate, are pointed to have a major role in depressive disorder.•Propionate mitigates brain region-specific dysregulation of epigenetic mechanisms. Major depressive disorder (MDD) is a global health concern, affecting over 250 million individuals worldwide. In recent years, the gut-brain axis has emerged as a promising field for understanding the pathophysiology of MDD. Microbial metabolites, such as short-chain fatty acids (SCFAs)—acetate, butyrate, and propionate-, have gained attention for their potential to influence epigenetic modifications within the host brain. However, the precise mechanisms through which these metabolites participate in MDD pathophysiology remain elusive. This study was designed to investigate the effects of oral SCFA supplementation in adult male Wistar rats subjected to chronic unpredictable mild stress (CUMS). A subset of control and CUMS-exposed rats received different supplementations: sodium acetate (NaOAc) at a concentration of 60 mM, sodium butyrate (NaB) at 40 mM, sodium propionate (NaP) at 50 mM, or a mixture of these SCFAs. The gut microbiome was assessed through 16S rRNA sequencing, and epigenetic profiling was performed using Western blot analysis. Results demonstrated that NaP supplementation significantly alleviated anhedonia in stressed animals, as evidenced by improved performance in the sucrose consumption test. This ameliorative effect was potentially associated with the modulation of gut bacterial communities, accompanied by the attenuation of the region-specific epigenetic dysregulation in the brain of the animals exposed to chronic stress. These findings suggest a potential association between gut dysbiosis and stress response, and NaP could be a promising target for future MDD interventions. However, further studies are needed to fully elucidate the underlying mechanisms of these effects. [Display omitted]
ISSN:0955-2863
1873-4847
1873-4847
DOI:10.1016/j.jnutbio.2024.109660